X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
female (28) 28
male (27) 27
index medicus (26) 26
aged (21) 21
middle aged (19) 19
pharmacokinetics (19) 19
adult (16) 16
pharmacology & pharmacy (16) 16
analysis (12) 12
patients (11) 11
risk factors (11) 11
midazolam (9) 9
oncology (9) 9
prospective studies (9) 9
medication adherence (8) 8
midazolam - pharmacokinetics (8) 8
pharmacology (8) 8
prognosis (8) 8
research (8) 8
abridged index medicus (7) 7
drug therapy (7) 7
health aspects (7) 7
hypnotics and sedatives - pharmacokinetics (7) 7
stroke (7) 7
usage (7) 7
atrial fibrillation (6) 6
cancer (6) 6
cardiac & cardiovascular systems (6) 6
care and treatment (6) 6
critical care medicine (6) 6
midazolam - administration & dosage (6) 6
midazolam - blood (6) 6
plasma (6) 6
risk (6) 6
aged, 80 and over (5) 5
antimitotic agents (5) 5
antineoplastic agents (5) 5
cancer research (5) 5
cardiovascular disease (5) 5
follow-up studies (5) 5
hypnotics and sedatives - administration & dosage (5) 5
incidence (5) 5
intensive care (5) 5
medical research (5) 5
medicine, experimental (5) 5
mortality (5) 5
netherlands (5) 5
pharmacodynamics (5) 5
prevention (5) 5
quality of life (5) 5
reproducibility of results (5) 5
retrospective studies (5) 5
sedation (5) 5
time factors (5) 5
adolescent (4) 4
anticoagulation (4) 4
chronic myeloid leukemia (4) 4
clinical medicine (4) 4
clinical trials (4) 4
complications and side effects (4) 4
dried blood spot (4) 4
dried blood spot testing - methods (4) 4
drug interactions (4) 4
drug monitoring - methods (4) 4
health risk assessment (4) 4
heart attacks (4) 4
hypnotics and sedatives - blood (4) 4
intensive care units (4) 4
leukemia (4) 4
lorazepam (4) 4
management (4) 4
medicine, general & internal (4) 4
models, biological (4) 4
patient compliance (4) 4
patients’ experiences (4) 4
risk assessment (4) 4
stroke - prevention & control (4) 4
tandem mass-spectrometry (4) 4
treatment outcome (4) 4
young adult (4) 4
atrial fibrillation - complications (3) 3
atrial fibrillation - drug therapy (3) 3
blood (3) 3
breast-cancer (3) 3
capecitabine (3) 3
cardiac arrhythmia (3) 3
cardiovascular diseases (3) 3
collaboration (3) 3
critically ill (3) 3
critically-ill patients (3) 3
dose-response relationship, drug (3) 3
drug dosages (3) 3
europe (3) 3
follow-up (3) 3
genetics (3) 3
hematology (3) 3
hypnotics and sedatives - pharmacology (3) 3
icu (3) 3
imatinib (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Critical care (London, England), ISSN 1466-609X, 05/2019, Volume 23, Issue 1, pp. 185 - 185
Antibiotic exposure in intensive care patients with sepsis is frequently inadequate and is associated with poorer outcomes. Antibiotic dosing is challenging in... 
MORTALITY | TARGET | Intensive care | Antibiotics | UNIT PATIENTS | MEDICAL-EDUCATION | ICU | Drug dosing | SEPSIS | Pharmacokinetics | CRITICALLY-ILL PATIENTS | CRITICAL CARE MEDICINE | Infection | Usage | Health aspects | Hypotheses | Hospitals | Collaboration | Critical care | Sepsis | Patients | Drug dosages
Journal Article
Chest, ISSN 0012-3692, 06/2018, Volume 153, Issue 6, pp. 1368 - 1377
Background: Early high-dose IV vitamin C is being investigated as adjuvant therapy in patients who are critically ill, but the optimal dose and infusion method... 
clinical trial | ascorbate | ascorbic acid | intensive care | pharmacology | CLINICAL-TRIAL | RESPIRATORY SYSTEM | CALCIUM | INTRAVENOUS ASCORBIC-ACID | SEPSIS | PREVENTS | CRITICAL CARE MEDICINE | Prevention | Care and treatment | Usage | Critically ill | Analysis | Adjuvant treatment | Clinical trials | Vitamin deficiency | Cancer
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 2019, Volume 75, Issue 6, pp. 825 - 829
To obtain insight into the feasibility of, and the patients' perspective on, dried blood spot (DBS) self-sampling by patients with chronic myeloid leukemia... 
Nilotinib | Self-sampling | Patients’ experiences | Chronic myeloid leukemia | Dried blood spot | Antimitotic agents | Medical research | Medical examination | Analysis | Leukemia | Medicine, Experimental | Antineoplastic agents | Blood | Demography | Myeloid leukemia | Feasibility studies | Patients | Demographics | Education | Collection | Feasibility | Clinical medicine | Sampling
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 08/2017, Volume 83, Issue 8, pp. 1676 - 1687
AimsThe muscarinic acetylcholine receptor antagonist scopolamine is often used for proof-of-pharmacology studies with pro-cognitive compounds. From a... 
Journal Article
Nederlands Tijdschrift voor Geneeskunde, ISSN 0028-2162, 2014, Volume 158, Issue 42
Journal Article
Chest, ISSN 0012-3692, 06/2018, Volume 153, Issue 6, pp. 1368 - 1377
Early high-dose IV vitamin C is being investigated as adjuvant therapy in patients who are critically ill, but the optimal dose and infusion method are... 
clinical trial | ascorbate | ascorbic acid | intensive care | pharmacology
Journal Article
Journal Article